University of Minnesota, Minneapolis, MN, USA.
HealthPartners Institute, Minneapolis, MN, USA.
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720932017. doi: 10.1177/2150132720932017.
Primary care is an ideal setting to deliver efficacious treatments for opioid use disorder (OUD). Primary care providers need to be aware of other concerns patients with OUD might have in order to provide comprehensive care. This study describes the prevalence of mental health, comorbid substance use, and psychosocial concerns of patients seeking treatment for OUD in primary care and their relation to 6-month treatment retention. Patients (N = 100; age = 34.9 years (SD = 10.8), 74% white, 46% female) with OUD who were starting treatment with buprenorphine at an academic family medicine residency clinic completed surveys of mental health concerns (depression, anxiety, trauma), psychosocial needs (food insecurity, income, transportation, employment), and demographic variables. Chart reviews were conducted to gather information on comorbid substance use, mental health diagnoses, and 6-month treatment retention. Mental health symptoms were highly prevalent in this sample (44% screened positive for anxiety, 31% for depression, and 52% for posttraumatic stress disorder). Three-quarters reported use of illicit substances other than opioids. Many patients also had significant psychosocial concerns, including unemployment (54%), low income (75%), food insecurity (51%), and lacking reliable transportation (64%). Two-thirds (67%) of the sample were retained at 6 months; patients who previously used intravenous opioids were more likely to discontinue treatment ( = .003). Many patients receiving treatment for OUD have significant mental health problems, comorbid substance use, and psychosocial concerns; interestingly, none of these factors predicted treatment retention at 6 months. Primary care clinics would benefit from having appropriate resources, interventions, and referrals for these comorbid issues in order to enhance overall patient well-being and promote recovery.
初级保健是提供有效的阿片类药物使用障碍 (OUD) 治疗的理想环境。初级保健提供者需要了解患有 OUD 的患者可能存在的其他问题,以便提供全面的护理。本研究描述了在初级保健中寻求 OUD 治疗的患者的心理健康、合并物质使用和心理社会问题的患病率,以及它们与 6 个月治疗保留率的关系。 接受纳曲酮治疗的 OUD 患者(N = 100;年龄 = 34.9 岁(SD = 10.8),74%为白人,46%为女性)在学术家庭医学居住实习诊所完成了心理健康问题(抑郁、焦虑、创伤)、心理社会需求(食物不安全、收入、交通、就业)和人口统计学变量的调查。进行病历回顾以收集合并物质使用、心理健康诊断和 6 个月治疗保留的信息。 该样本中精神健康症状高度普遍(44%焦虑筛查阳性,31%抑郁筛查阳性,52%创伤后应激障碍筛查阳性)。四分之三的患者报告使用除阿片类药物以外的非法物质。许多患者还存在严重的心理社会问题,包括失业(54%)、收入低(75%)、食物不安全(51%)和缺乏可靠的交通(64%)。该样本中有三分之二(67%)的患者在 6 个月时保留下来;之前使用静脉内阿片类药物的患者更有可能停止治疗( =.003)。 许多接受 OUD 治疗的患者都有严重的心理健康问题、合并物质使用和心理社会问题;有趣的是,这些因素都不能预测 6 个月时的治疗保留率。初级保健诊所将受益于为这些合并问题提供适当的资源、干预措施和转介,以提高整体患者福祉并促进康复。